BriaCell Therapeutics (BCTX) Institutional Ownership $0.48 -0.01 (-2.19%) (As of 01:30 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BriaCell Therapeutics (NASDAQ:BCTX)CurrentInstitutional OwnershipPercentage15.42%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$718.23KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.49M Get BCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCTX Institutional Buying and Selling by Quarter Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… BriaCell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/29/2024 Onyx Bridge Wealth Group LLC50,000$143K0.0%+66.7%0.313% 4/27/2024 K.J. Harrison & Partners Inc87,044$249K0.0%+7.8%0.545% 2/14/2024 Wasatch Advisors LP267,410$1.56M0.0%-48.0%1.673% 2/12/2024 Redmond Asset Management LLC133,569$781K0.3%-3.1%0.836% 2/6/2024 National Bank of Canada FI7,500$40K0.0%+200.0%0.047% 2/2/2024 K.J. Harrison & Partners Inc80,715$476K0.1%+22.1%0.505% Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024 Onyx Bridge Wealth Group LLC30,000$176K0.0%N/A0.188% 11/13/2023 K2 Principal Fund L.P.24,969$156K0.0%N/A0.156% 10/31/2023 K.J. Harrison & Partners Inc66,090$411K0.1%+90.8%0.414% 10/25/2023 Concord Wealth Partners10,775$67K0.0%-29.5%0.067% 8/11/2023 Natixis90,250$579K0.0%N/A0.565% 8/8/2023 Wasatch Advisors LP612,088$3.93M0.0%-0.6%3.830% 8/8/2023 Concord Wealth Partners15,275$98K0.0%-14.1%0.096% 8/2/2023 Bank of Montreal Can34,629$217K0.0%N/A0.217% 7/21/2023 K.J. Harrison & Partners Inc34,640$217K0.0%-67.3%0.217% 4/25/2023 K.J. Harrison & Partners Inc105,933$785K0.2%-75.2%0.683% 2/7/2023Lynwood Capital Management Inc.1,530,000$6.69M8.0%+27.7%9.860% 1/25/2023 K.J. Harrison & Partners Inc427,583$2.52B0.5%-10.9%2.755% 11/8/2022 Apollon Wealth Management LLC17,900$101K0.0%+12.6%0.115% 11/7/2022 Virtu Financial LLC48,347$272K0.0%+362.5%0.312% 10/25/2022Lynwood Capital Management Inc.1,198,000$6.73M7.4%+94.8%7.720% 10/21/2022 K.J. Harrison & Partners Inc479,838$2.75M1.0%-70.1%3.092% 8/11/2022 Apollon Wealth Management LLC15,900$92K0.0%+14.4%0.102% 8/2/2022Lynwood Capital Management Inc.615,000$3.55M4.0%-18.0%3.963% 7/27/2022 K.J. Harrison & Partners Inc1,607,027$9.19M2.5%+18.9%10.355% 5/5/2022Lynwood Capital Management Inc.750,000$7.61M8.2%-4.5%4.908% 4/21/2022 K.J. Harrison & Partners Inc1,351,782$13.75M2.2%N/A8.847% 4/20/2022 Concord Wealth Partners16,775$170K0.0%+31.3%0.110% 2/9/2022 Insight Advisors LLC PA16,900$140K0.0%N/A0.106% 2/3/2022 Total Clarity Wealth Management Inc.15,818$131K0.1%+38.5%0.099% 1/21/2022 Concord Wealth Partners12,775$106K0.0%N/A0.080% 11/16/2021 Two Sigma Investments LP62,139$503K0.0%N/A0.404% 11/16/2021 Voloridge Investment Management LLC156,946$1.27M0.0%N/A1.021% 10/22/2021 Redmond Asset Management LLC136,593$1.11M0.3%+3.7%0.890% 10/21/2021 Total Clarity Wealth Management Inc.11,425$93K0.0%N/A0.074% 10/19/2021 Belvedere Trading LLC13,608$107K0.0%N/A0.089% 10/13/2021 FNY Investment Advisers LLC4,687$37K0.0%N/A0.031% 10/13/2021Gofen & Glossberg LLC IL10,000$81K0.0%N/A0.065% 8/25/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/17/2021 Armistice Capital LLC570,343$3.04M0.1%N/A3.735% My big AI project… (Ad)On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register.8/16/2021 Sabby Management LLC196,033$1.05M0.1%+22.4%1.284% 8/16/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/13/2021 Altium Capital Management LP800,295$4.27M1.0%N/A5.241% 8/13/2021 Murchinson Ltd.250,000$1.33M0.5%N/A1.637% 8/12/2021 MMCAP International Inc. SPC400,000$2.13M0.1%N/A2.620% 8/12/2021 Kepos Capital LP500,000$2.67M0.2%N/A3.274% 8/12/2021 Eqis Capital Management Inc.21,182$113K0.0%+29.6%0.139% 8/11/2021CVI Holdings LLC320,800$1.71M0.1%N/A2.101% 5/19/2021 Virtu Financial LLC15,121$58K0.0%N/A0.260% 5/14/2021 Eqis Capital Management Inc.16,339$63K0.0%N/A0.281% 5/6/2021 Redmond Asset Management LLC131,731$508K0.2%N/A2.266% (Data available from 1/1/2016 forward) BCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of BriaCell Therapeutics. The most heavily invested institutionals were Lynwood Capital Management Inc. ($6.69M), Wasatch Advisors LP ($1.56M), Redmond Asset Management LLC ($781K), Natixis ($579K), Virtu Financial LLC ($272K), K.J. Harrison & Partners Inc ($249K), and Bank of Montreal Can ($217K).Learn more on BCTX's institutional investors. What percentage of BriaCell Therapeutics stock is owned by institutional investors? 15.42% of BriaCell Therapeutics stock is owned by institutional investors. Learn more on BCTX's institutional investor holdings. Which institutional investors have been buying BriaCell Therapeutics stock? Of the 9 institutional investors that purchased BriaCell Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynwood Capital Management Inc. ($915K), Natixis ($90.25K), K.J. Harrison & Partners Inc ($52.40K), Onyx Bridge Wealth Group LLC ($50K), Virtu Financial LLC ($37.89K), Bank of Montreal Can ($34.63K), and K2 Principal Fund L.P. ($24.97K). How much institutional buying is happening at BriaCell Therapeutics? Institutional investors have bought a total of 1,212,146 shares in the last 24 months. This purchase volume represents approximately $6.47M in transactions. Which BriaCell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold BriaCell Therapeutics stock in the last 24 months: K.J. Harrison & Partners Inc ($1.57M), Wasatch Advisors LP ($250.34K), Concord Wealth Partners ($7K), and Redmond Asset Management LLC ($4.27K). How much institutional selling is happening at BriaCell Therapeutics? Institutional investors have sold a total of 1,833,998 shares in the last 24 months. This volume of shares sold represents approximately $10.95M in transactions. Related Companies: VTVT Major Shareholders AADI Major Shareholders LEXX Major Shareholders MNPR Major Shareholders YS Major Shareholders SYRS Major Shareholders CARM Major Shareholders KZR Major Shareholders AKTX Major Shareholders FBIO Major Shareholders This page (NASDAQ:BCTX) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredWar on Elon Escalates… One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows th...Porter & Company | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Altcoin for September 2024With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.